Mitchell Memorial Cancer Center Cancer Care - Owensboro Health

You Can. You Can Get National - Quality Cancer Care, Right Here!

Owensboro Health has earned accreditations from multiple, national accrediting healthcare organizations, including the American College of Surgeons Commission on Cancer, the American College of Radiology and the National Accreditation Program for Breast Centers. By meeting their standards, which are set by the best and brightest leaders in these disciplines of cancer care, Owensboro Health shows that we are delivering care at the same level as the best cancer care centers around the country.

Our Research and Affiliate relationship with UK Markey Cancer Center, Kentucky’s only National Cancer Institute-designated cancer center affords us leading-edge cancer care and groundbreaking research, alongside hundreds of national clinical trials – some clinical trials offer the most advanced research, therapies, and medicine available to date.

At Owensboro Health, "You Can." You can get national - quality cancer care, right here. 

Our mission calls for us to fight cancer at all points.

  • To prevent cancer when possible through lifestyle changes
  • To diagnose cancer as early as possible through preventive screenings
  • To treat those diagnosed with cancer to the fullest extent
  • To assist patients with follow-up care and surveillance
  • To help patients get back to their best life 

Schedule Your Lung Screening

Lung cancer often doesn't show symptoms in its initial stages. That's why you may benefit from a low-dose CT lung screening that helps detect the disease early - when treatment works best.

Foundation for Lung Cancer Center of Excellence screening - Delivering excellence in responsible screening

What our patients are saying

"I could not have made it through this without all of the people involved. The cancer center, my grandchildren, my children, my family and friends, they’ve all been a big help."

Cindy Reed, Breast Cancer Survivor

"Dr. Mahewshwari treats you like a human being. With his bedside manner, you don't feel like a patient. You feel more like a family member. He's good." 

Alan King, Non-Hodgkin Lymphoma Survivor

gray background

Owensboro Health & UK: Working Together to benefit our communities

We’re proud to work with the University of Kentucky’s Markey Cancer Center. Whether it’s through offering more clinical trials or further enhancing the quality and safety of our care, we see that by working together, we can do even more for our patients and people throughout our communities.

At Owensboro Health, we are proud of our history of clinical cancer excellence. Our Research and Affiliate relationships with UK Markey Cancer Center, Kentucky’s only National Cancer Institute designated cancer center and one of only 69 in the nation, prove especially worthwhile in caring for cancer patients in our region.

Our relationship with UK Markey Cancer Center affords us leading-edge cancer care and groundbreaking research, alongside hundreds of national clinical trials and the most advanced research, therapies and medicine available to date.

Owensboro Health’s alliance with UK Markey Cancer Center also allows patients access to the state’s only molecular tumor board and UK’s early phase clinical trials center, giving patients access to the most up-to-date technologies and therapies, while also giving them more treatment options based on their unique genetic characteristics of their particular cancer.

"Modern cancer care is never delivered by just one doctor. It's done with a team approach. Our relationships with UK follows that same model."

Greg Strahan, Owensboro Health President & CEO

Molecular Tumor Board

A patient is tested for genetic mutations known to cause cancer, regardless of what type of tumor. The Molecular Tumor Board then uses these genetic mutations to consider possible treatment options for the patient. 

"Through the UK Markey Cancer Center Molecular Tumor Board, a team of physicians receives the molecular specifics of a patient's tumor and provides information back to the community physician on the latest treatment options that might work for that patient."

Genetic mutations are evaluated for FDA-approved therapies for the patient’s tumor type, other FDA-approved therapies in other tumor types and any clinical trials available related to the specific genetic mutations.

Taking into consideration the total treatment options available, the Molecular Tumor Board makes a treatment recommendation based on the best possible outcome for the patient.

Precision Medicine

Precision medicine uses genetic analysis to help oncologists choose cancer therapies attuned to EACH patient's individual needs. 

"Oncology is now more genetic-based whereas in years past it was based on tumor types. By understanding patient's tumors and their genetic makeup, we are able to more positively direct a patient's therapy."

Dr. Mark Evers, Director, UK Markey Cancer Center

UK Markey Cancer Center's Precision Medicine Clinic uses investigator-initiated trials, offering access to phase I and phase II clinical trials and new treatment avenues for cancers that may have proved difficult to target through standard therapies.

Accreditation

Owensboro Health’s Mitchell Memorial Cancer Center is dedicated to providing care that meets nationally accepted standards to residents of Kentucky and Indiana. To demonstrate that commitment, the center has earned accreditation by multiple governing healthcare bodies, reflecting that we deliver national-quality treatment in keeping with the highest recognized standards of care. The process of accreditation is rigorous. We are proud to have earned these accreditations, in keeping with our mission to heal the sick and to improve the health of the communities we serve.

The following accreditations have been earned by Owensboro Health’s Mitchell Memorial Cancer Center:

The American College of Surgeons Commission on Cancer

Established in 1922, the Commission on Cancer (CoC) is a consortium of professional organizations dedicated to improving patient outcomes and quality of life for cancer patients through standard-setting, prevention, research, education and the monitoring of comprehensive quality care. 

In 2015, Owensboro Health’s Mitchell Memorial Cancer Center received the CoC’s "Outstanding Achievement Award" the highest possible award given for CoC accreditation. The Outstanding Achievement Award is granted to accredited cancer programs that receive compliance ratings for 27 standards as well as commendation ratings for seven standards. These 34 cancer program standards reflect program management, clinical services, a continuum of care services, patient outcomes and data quality. 

The American College of Surgeons National Accreditation Program for Breast Centers

This accreditation is awarded to facilities which voluntarily commit to providing the highest level of breast care. This accreditation requires a rigorous process of evaluation, survey and review before being granted. 

The American College of Radiology Certificate of Accreditation in Radiation Oncology Services

The American College of Radiology (ACR) requires all facilities that seek accreditation to demonstrate a commitment to following nationally accepted standards of care. The process also includes a peer-review evaluation process involving respected experts in the field of radiation oncology.

The Radiation Oncology Accreditation Program provides third-party, impartial peer review and evaluation of patient care. Staff, equipment, treatment planning and records, patient safety and quality control activities are assessed.

American College of Radiology Lung Cancer Screening Program

Owensboro Health was one of the first sites in Kentucky to join the Kentucky Clinical Trial Network for tobacco-related cancers and was one of the first centers in Kentucky to offer low-dose CT lung cancer screening. It is an ACR Designated Lung Cancer Screening Center.

© 2019